YUVANCI cpr pell 10 mg/40 mg 30 pce
7680694460026
CH-69446
C02KX54
02.07.1.
Reimbursement limitations:
YUVANCI
YUVANCI est remboursé pour le traitement à long terme de l'hypertension artérielle pulmonaire (HTAP) chez …
1 / 2
google
Details
- Product number
- 6944602
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- Filmtablette: macitentanum 10 mg, tadalafilum 40 mg, lactosum monohydricum 250.86 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, povidonum K 30, polysorbatum 80, hydroxypropylcellulosum substitutum humile, natrii laurilsulfas, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.32 mg, triacetinum, talcum, E 171, pro compresso obducto, natrium 2.16 mg.
Articles (1)
Yuvanci 10 mg/40 mg, Filmtabletten
Filmtabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
250.86 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
2.32 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
2.16 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2992.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2025
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69446
- Drug name
- Yuvanci, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C02KX54
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/10/2024
- Authorization expiration date
- 09/10/2029
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- YUVANCI cpr pell 10 mg/40 mg 30 pce
- Description (DE)
- YUVANCI Filmtabl 10 mg/40 mg 30 Stk
- Market launch
- 10/10/2024
- Narcotic (BTM)
- No